
- /
- Supported exchanges
- / US
- / STAA.NASDAQ
STAAR Surgical Company (STAA NASDAQ) stock market data APIs
STAAR Surgical Company Financial Data Overview
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get STAAR Surgical Company data using free add-ons & libraries
Get STAAR Surgical Company Fundamental Data
STAAR Surgical Company Fundamental data includes:
- Net Revenue: 279 M
- EBITDA: -36 822 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-30
- EPS/Forecast: -0.5756
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
STAAR Surgical Company News

The STAAR Surgical Company (NASDAQ:STAA) First-Quarter Results Are Out And Analysts Have Published New Forecasts
It's been a good week for STAAR Surgical Company (NASDAQ:STAA) shareholders, because the company has just released its latest first-quarter results, and the shares gained 2.0% to US$19.42. Revenues of...


Staar Surgical Co (STAA) Q1 2025 Earnings Call Highlights: Navigating Challenges and Optimizing ...
Release Date: May 07, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Staar Surgical Co (NASDAQ:STAA) has streamlined its m...

Staar Surgical (STAA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended March 2025, Staar Surgical (STAA) reported revenue of $42.59 million, down 45% over the same period last year. EPS came in at -$0.52, compared to $0.06 in the year-ago quarter. ...

STAAR Surgical (NASDAQ:STAA) Exceeds Q1 Expectations
Medical lens company STAAR Surgical (NASDAQ:STAA) reported Q1 CY2025 results exceeding the market’s revenue expectations , but sales fell by 44.9% year on year to $42.59 million. Its GAAP loss of $1...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.